Organ Dysfunction and Muscular Disability in Myotonic Dystrophy Type 1

被引:37
|
作者
Kaminsky, Pierre [1 ]
Poussel, Mathias [1 ,2 ]
Pruna, Lelia
Deibener, Joelle
Chenuel, Bruno [1 ,2 ]
Brembilla-Perrot, Beatrice
机构
[1] Ctr Hosp Univ Nancy, Hop Brabois, F-54500 Vandoeuvre Les Nancy, France
[2] Nancy Univ, EA3450, Fac Med, Nancy, France
关键词
CARDIAC INVOLVEMENT; CTG-REPEAT; METABOLIC SYNDROME; MUSCLE WEAKNESS; SUDDEN-DEATH; ABNORMALITIES; DISEASE; LENGTH; RNA; PATHOGENESIS;
D O I
10.1097/MD.0b013e318226046b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myotonic dystrophy type 1 (DM1) is a multisystemic disorder characterized by muscle weakness and multiple organ impairment, especially the eyes, lung, and heart. We conducted the current study to analyze the prevalence and intercorrelation among these disorders and their respective relationships with muscular disability. We assessed medical history, anthropometric data, lung volumes, arterial and venous blood samples, surface 12-lead electrocardiogram, echocardiography, ophthalmologic examination, and muscular impairment rating scale (MIRS) in 106 patients (48 male and 58 female) with DM1, aged 43.7 +/- 12.8 years. Obesity, hypertriglyceridemia, and diabetes were found in respectively 25.6%, 47.6%, and 17.1% of patients. Disabling cataract was found in 43.4%, and was independently predicted by age and MIRS. Restrictive lung disease was noted in 34%, and was predicted by MIRS, CTG repeat expansion, and body mass index. Conduction disorders were found in 30.2% of patients and were predicted by left ventricular ejection fraction, MIRS, and CTG repeat expansion. We found significant relationships between cataract, restrictive lung disease, and conduction disorders: patients with cataract and those with conduction disorders exhibited more severe restrictive lung disease than the other patients. Conversely, the relative risk of restrictive lung disease was 2.42 (1% confidence interval [CI], 1.06-5.51) in patients with cataract and 2.54 (1% CI, 1.26-5.07) in patients with conduction disorders. Multivariate analysis revealed that MIRS was the only independent predictor for conduction disorders and restrictive lung disease. MIRS >= 3 and MIRS >= 4 were the best simple cutoff values to predict, respectively, lung and cardiac involvements. To conclude, muscular disability, ophthalmologic, and cardiac and pulmonary involvement are strongly correlated. Particular attention should be given to these entities in patients with distal or proximal muscular weakness.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 50 条
  • [31] Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
    Kersten, Hannah M.
    Roxburgh, Richard H.
    Child, Nicholas
    Polkinghorne, Philip J.
    Frampton, Chris
    Danesh-Meyer, Helen V.
    JOURNAL OF NEUROLOGY, 2014, 261 (01) : 37 - 44
  • [32] Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
    Hannah M. Kersten
    Richard H. Roxburgh
    Nicholas Child
    Philip J. Polkinghorne
    Chris Frampton
    Helen V. Danesh-Meyer
    Journal of Neurology, 2014, 261 : 37 - 44
  • [33] Respiratory pattern during water swallowing in patients with Duchenne muscular dystrophy and myotonic dystrophy type 1
    Nozaki, S.
    Sugishita, S.
    Umaki, Y.
    Matsumura, T.
    Tatara, K.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 645 - 645
  • [34] MYOTONIC MUSCULAR-DYSTROPHY
    ALBERTS, MJ
    ROSES, AD
    NEUROLOGIC CLINICS, 1989, 7 (01) : 1 - 8
  • [35] Physical disability in myotonic dystrophy
    Phillips, MF
    Mathieu, J
    MYOTONIC DYSTROPHY: PRESENT MANAGEMENT, FUTURE THERAPY, 2004, : 68 - 82
  • [36] Diagnostic Criteria of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1
    Di Toro, Alessandro
    Giuliani, Lorenzo
    Serio, Alessandra
    Arbustini, Eloisa
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : 857 - 859
  • [37] Influences of Facioscapulohumeral Muscular Dystrophy (FSHD) and Myotonic Dystrophy Type 1 (DM1) on Motor Speech Performance
    Doering, E.
    Schroeter, C.
    Schnitker, R.
    SPRACHE-STIMME-GEHOR, 2013, 37 : E45 - E46
  • [38] The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1
    Russo, Vincenzo
    Papa, Andrea Antonio
    Nigro, Gerardo
    JAMA CARDIOLOGY, 2017, 2 (09) : 1044 - 1044
  • [39] Genetic markers of myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) in human urine
    Antoury, Layal
    Hu, Ningyan
    Balaj, Leonora
    Breakefield, Xandra
    Wheeler, Thurman
    NEUROLOGY, 2017, 88
  • [40] Dehydroepiandrosterone for myotonic dystrophy type 1
    Penisson-Besnier, I.
    Devillers, M.
    Porcher, R.
    Orlikowski, D.
    Doppler, V.
    Desnuelle, C.
    Ferrer, X.
    Bes, M. -C. A.
    Bouhour, F.
    Tranchant, C.
    Lagrange, E.
    Vershueren, A.
    Uzenot, D.
    Cintas, P.
    Sole, G.
    Hogrel, J. -Y.
    Laforet, P.
    Vial, C.
    Vila, A. L.
    Sacconi, S.
    Pouget, J.
    Eymard, B.
    Chevret, S.
    Annane, D.
    NEUROLOGY, 2008, 71 (06) : 407 - 412